AbCellera – Should You Sell This Stock After Recent Rally?
Company Overview AbCellera is a clinical-stage biotechnology firm focused on discovering and developing antibody-based therapeutics using its proprietary technology platforms. The company collaborates with partners to identify therapeutic antibody candidates and advance internal programs toward clinical development. Volatile Financial Performance AbCellera’s revenue has fluctuated significantly on a quarterly and annual basis. Historical results have not…


